Research ArticleVaccines

Nucleoside-modified mRNA vaccination partially overcomes maternal antibody inhibition of de novo immune responses in mice

See allHide authors and affiliations

Science Translational Medicine  08 Jan 2020:
Vol. 12, Issue 525, eaav5701
DOI: 10.1126/scitranslmed.aav5701

Article Information

vol. 12 no. 525

PubMed: 
Print ISSN: 
Online ISSN: 
History: 
  • Received for publication September 28, 2018
  • Resubmitted June 21, 2019
  • Accepted for publication September 23, 2019
  • .

Author Information

  1. Elinor Willis1,
  2. Norbert Pardi2,
  3. Kaela Parkhouse1,
  4. Barbara L. Mui3,
  5. Ying K. Tam3,
  6. Drew Weissman2 and
  7. Scott E. Hensley1,*
  1. 1Department of Microbiology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA 19104, USA.
  2. 2Department of Medicine, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA 19104, USA.
  3. 3Acuitas Therapeutics, Vancouver, BC V6T 1Z3, Canada.
  1. *Corresponding author. Email: hensley{at}pennmedicine.upenn.edu

Altmetric

Article usage

Article usage: January 2020 to July 2020

AbstractFullPdf
Jan 20204874751358
Feb 202049810372
Mar 20203617955
Apr 20202686163
May 20203677465
Jun 20202505843
Jul 202019102

Stay Connected to Science Translational Medicine